{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T20:48:04Z","timestamp":1793134084604,"version":"4.5.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.intimp.2022.108636","type":"journal-article","created":{"date-parts":[[2022,2,24]],"date-time":"2022-02-24T14:55:34Z","timestamp":1645714534000},"page":"108636","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Diversity of complement activation in different thyroid diseases"],"prefix":"10.1016","volume":"106","author":[{"given":"Chenxu","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jumei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guizhi","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junqing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohui","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"14","key":"10.1016\/j.intimp.2022.108636_b0005","first-page":"1058","article-title":"Complement. first of two parts","volume":"344","author":"Mackay","year":"2001","journal-title":"N. Engl. J. Med."},{"issue":"15","key":"10.1016\/j.intimp.2022.108636_b0010","first-page":"1140","article-title":"Complement. second of two parts","volume":"344","author":"Mackay","year":"2001","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.intimp.2022.108636_b0015","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.semnephrol.2013.08.001","article-title":"Overview of complement activation and regulation","volume":"33","author":"Noris","year":"2013","journal-title":"Semin. Nephrol."},{"issue":"10","key":"10.1016\/j.intimp.2022.108636_b0020","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1097\/DAD.0000000000001817","article-title":"Immunoglobulin and complement immunohistochemistry on paraffin sections in autoimmune bullous diseases: a systematic review and meta-analysis","volume":"43","author":"Kasperkiewicz","year":"2021","journal-title":"Am. J. Dermatopathol."},{"issue":"2","key":"10.1016\/j.intimp.2022.108636_b0025","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s12016-019-08774-5","article-title":"The immunopathology of complement proteins and innate immunity in autoimmune disease","volume":"58","author":"Defendi","year":"2020","journal-title":"Clin. Rev. Allergy Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2022.108636_b0030","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3390\/antib9040057","article-title":"Complement system: promoter or suppressor of cancer progression?","volume":"9","author":"Revel","year":"2020","journal-title":"Antibodies (Basel)"},{"key":"10.1016\/j.intimp.2022.108636_b0035","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.molimm.2017.05.013","article-title":"Complement in clinical medicine: clinical trials, case reports and therapy monitoring","volume":"89","author":"Ricklin","year":"2017","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.intimp.2022.108636_b0040","unstructured":"S.M. Ferrari, P. Fallahi, G. Elia, F. Ragusa, I. Ruffilli, S.R. Paparo, A. Antonelli, Thyroid autoimmune disorders and cancer, Semin Cancer Biol (2019) pii: S1044-579X(18)30159-7."},{"issue":"18","key":"10.1016\/j.intimp.2022.108636_b0045","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20184413","article-title":"Immune and inflammatory cells in thyroid cancer microenvironment","volume":"20","author":"Ferrari","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.intimp.2022.108636_b0050","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.autrev.2014.10.016","article-title":"Autoimmune thyroid disorders","volume":"14","author":"Antonelli","year":"2015","journal-title":"Autoimmun. Rev."},{"issue":"1","key":"10.1016\/j.intimp.2022.108636_b0055","first-page":"25","article-title":"Terminal complement complexes and C1\/C1 inhibitor complexes in autoimmune thyroid-disease","volume":"77","author":"Weetman","year":"1989","journal-title":"Clin. Exp. Immunol."},{"issue":"12","key":"10.1016\/j.intimp.2022.108636_b0060","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0046-8177(96)90346-9","article-title":"Tumor-specific deposition of immunoglobulin G and complement in papillary thyroid carcinoma","volume":"27","author":"Lucas","year":"1996","journal-title":"Hum. Pathol."},{"issue":"11","key":"10.1016\/j.intimp.2022.108636_b0065","doi-asserted-by":"crossref","first-page":"2808","DOI":"10.1002\/1097-0142(19940601)73:11<2808::AID-CNCR2820731125>3.0.CO;2-P","article-title":"Protection of thyroid cancer cells by complement-regulatory factors","volume":"73","author":"Yamakawa","year":"1994","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.intimp.2022.108636_b0070","first-page":"643","article-title":"Expression and function of multiple regulators of complement activation in autoimmune thyroid-disease","volume":"81","author":"Tandon","year":"1994","journal-title":"Immunology"},{"issue":"2","key":"10.1016\/j.intimp.2022.108636_b0075","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1210\/jc.2014-2921","article-title":"Changes in anti-thyroglobulin IgG glycosylation patterns in Hashimoto's thyroiditis patients","volume":"100","author":"Yuan","year":"2015","journal-title":"J. Clin. Endocr. Metab."},{"issue":"12","key":"10.1016\/j.intimp.2022.108636_b0080","doi-asserted-by":"crossref","first-page":"5422","DOI":"10.1210\/en.2003-0918","article-title":"Complement activation by direct C4 binding to thyroperoxidase in Hashimoto's thyroiditis","volume":"144","author":"Blanchin","year":"2003","journal-title":"Endocrinology"},{"issue":"6947","key":"10.1016\/j.intimp.2022.108636_b0085","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/S0140-6736(56)92249-8","article-title":"Auto-antibodies in Hashimoto's disease (lymphadenoid goitre)","volume":"268","author":"Roitt","year":"1956","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.intimp.2022.108636_b0090","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1210\/jc.2007-2042","article-title":"Antithyroperoxidase antibody-dependent cytotoxicity in autoimmune thyroid disease","volume":"93","author":"Rebuffat","year":"2008","journal-title":"J. Clin. Endocr. Metab."},{"issue":"2","key":"10.1016\/j.intimp.2022.108636_b0095","first-page":"383","article-title":"Studies of complement activation and IgG subclass restriction of anti-thyroglobulin","volume":"56","author":"Adler","year":"1984","journal-title":"Clin. Exp. Immunol."},{"issue":"6","key":"10.1016\/j.intimp.2022.108636_b0100","first-page":"599","article-title":"Glycosylation changes of IgG associated with rheumatoid-arthritis can activate complement via the mannose-binding protein","volume":"1","author":"Malhotra","year":"1995","journal-title":"Nat. Med."},{"issue":"8","key":"10.1016\/j.intimp.2022.108636_b0105","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/0161-5890(83)90076-7","article-title":"Interaction of C3 and C3b with immunoglobulin G","volume":"20","author":"Kulics","year":"1983","journal-title":"Mol. Immunol."},{"issue":"8","key":"10.1016\/j.intimp.2022.108636_b0110","doi-asserted-by":"crossref","first-page":"5866","DOI":"10.1016\/S0021-9258(18)53400-1","article-title":"Identification of a major binding-site for complement C3 on the IgG1 heavy-chain","volume":"268","author":"Shohet","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.intimp.2022.108636_b0115","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.molimm.2019.07.032","article-title":"Is generation of C3(H2O) necessary for activation of the alternative pathway in real life?","volume":"114","author":"Ekdahl","year":"2019","journal-title":"Mol. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2022.108636_b0120","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1365-2249.1990.tb05405.x","article-title":"Thyroid follicular cell-function after nonlethal complement membrane attack","volume":"82","author":"Weetman","year":"1990","journal-title":"Clin. Exp. Immunol."},{"issue":"8820","key":"10.1016\/j.intimp.2022.108636_b0125","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/0140-6736(92)92171-B","article-title":"Antithyroid drugs and release of inflammatory mediators by complement-attacked thyroid-cells","volume":"340","author":"Weetman","year":"1992","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.intimp.2022.108636_b0130","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.3390\/cancers13061209","article-title":"Complement in tumourigenesis and the response to cancer therapy","volume":"13","author":"O\u2019Brien","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.intimp.2022.108636_b0135","doi-asserted-by":"crossref","first-page":"752","DOI":"10.3389\/fimmu.2019.00752","article-title":"Complement C5b\u20139 and cancer: mechanisms of cell damage, cancer counteractions, and approaches for intervention","volume":"10","author":"Fishelson","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2022.108636_b0140","doi-asserted-by":"crossref","unstructured":"F. Niculescu, T. Badea, H. Rus, Sublytic C5b-9 complexes induce proliferation of human aortic smooth muscle cells. Role of mitogen-activated protein kinase and phosphatidylinositol 3-kinase, Xiii World Congress of Cardiology (1998) 1185-1190.","DOI":"10.1016\/S0161-5890(98)90809-4"},{"issue":"6","key":"10.1016\/j.intimp.2022.108636_b0145","first-page":"788","article-title":"Autoimmune thyroid-disease - further developments in our understanding","volume":"15","author":"Weetman","year":"1994","journal-title":"Endocr. Rev."},{"issue":"5","key":"10.1016\/j.intimp.2022.108636_b0150","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1007\/s40618-020-01477-1","article-title":"An update on the pathogenesis of Hashimoto's thyroiditis","volume":"44","author":"Weetman","year":"2021","journal-title":"J. Endocrinol. Invest."},{"issue":"3","key":"10.1016\/j.intimp.2022.108636_b0155","first-page":"1038","article-title":"Age and gender predict the outcome of treatment for Graves' hyperthyroidism","volume":"85","author":"Allahabadia","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576922001205?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576922001205?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:35:25Z","timestamp":1761586525000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576922001205"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":31,"alternative-id":["S1567576922001205"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2022.108636","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diversity of complement activation in different thyroid diseases","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2022.108636","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108636"}}